Hong Kong Baptist University

Other

Shanghai University of Traditional Chinese

Dajian Yang

Zhaoxiang Bian

Aiping Lu

Hongxi Xu

Shilin Chen

Kaixian Chen

Chengyuan Lin

Albert Sun Chi Chan

Albert Sun-Chi Chan

Siu Wai Tsang

Huaixue Mu

Hong Jie Zhang

Yuanzhi Lao

Xiaoyu Wang

Sun Chi Albert Chan

Hongjie Zhang

Quanbin Han

Xin Li

Yegao Chen

Ruihong Gong

Aiping Lyu

Hongsheng Tan

Linfang Huang

Yue Lv

Haitao Xiao

Guoqing Chen

Wenwei Fu

Hongyan Qin

Provided is a combined pharmaceutical composition of HF and ansesquiterpene lactone compound for treating cancers. The active ingredients of the combined pharmaceutical composition consist of HF and ansesquiterpene lactone compound. HF and ATS have significant synergistic effect. The activity of the combined pharmaceutical of HF and ATS is comparable or even higher than that of the anti-cancer drug 5-FU.

Anti-cancer composition consisting of halofuginone and sesquiterpene lactone compounds of artemisia apiacea and use thereof

A compound of formula (I) or a pharmaceutically acceptable salt, hydrate or prodrug thereof for inhibiting Syk activity, 

Method for preventing and/or treating a subject suffering from asthma

The present invention relates to chemical constituents of the hydro-alcoholic extract of root of(L.) Thwait. More particularly, it relates to the bioactive chemical composition of(L.) Thwait and its anticancer effect. The present invention has application in the treatment of human esophageal carcinoma.

[object Object]

The present invention provides a compound, namely (+)-3'-Angeloyloxy-4&#x2032;-keto-3&#x2032;,4&#x2032;-dihydroseselin (Pd-Ib) derived fromas the potential anti-inflammation drug. The present invention also relates to methods of preparing the compounds and using the same for treating inflammation.

(+)-3'-angeloyloxy-4&#x2032;-keto-3&#x2032;,4&#x2032;-dihydroseselin for treating inflammation

Prostate cancer is the most commonly diagnosed cancer in males and one of the leading causes of cancer death. Although treatment options have increased for some patients, overall progress has been modest. Thus, there is a great need to develop new treatments. This invention relates to a method for treating cancer comprising using an anti-cancer compound of formula (I):  More particularly, it relates to said anti-prostate cancer compound that can be isolated fromor chemically synthesized and its specific anticancer/antitumor activity. The invention has a specific application in treating human prostate cancer.

Pharmaceutical composition comprising guttiferone F for the treatment of prostate cancer

Cervical cancer is one of the most common malignancies and is associated with a dismal prognosis. The most common therapeutic option for cervical cancer consists of surgery in early stages, and chemotherapy or radiotherapy in more advanced stages of the disease. Although treatment options have increased for some patients, overall progress has been modest. This invention relates to a method for treating cancer comprising administering an anti-cancer compound. More particularly, the present invention relates to an anti-cervical-cancer compound for treating human cervical cancer and tumor.

Anti-cervical cancer compound and method of use thereof

A method for suppressing activation of pancreatic stellate cells of a subject includes administering a composition comprising a therapeutically effective amount of Eruberin A. A method of preventing, alleviating or treating pancreatic tumors or pancreatic tumors related diseases includes administering a composition comprising a therapeutically effective amount of Eruberin A. The Eruberin A may be extracted from

Use of a flavanol glycoside for suppressing activation of stellate cells

The present invention relates to a method of using an anthraquinone derivative namely 9,10-Dihydro-4,5-dihydroxy-9,10-dioxo-2-anthracenecarboxylic acid, or known as Rhein, for treating chronic pancreatitis induced fibrosis of the pancreas. More particularly, the present invention relates to a method of using Rhein, its derivatives and/or chemical variants as an anti-fibrotic agent. The present invention particularly relates to the suppression of pancreatic stellate cell activation for the management of chronic inflammatory, fibrotic and tumorigenic pathologies in the pancreas.

Method of using rhein for treating fibrotic conditions and tumors

Growing community of inventors

Hong Kong, China

Dajian Yang